TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: <10nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of mouse recombinant CLK1 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of recombinant VEGFR2 using poly(Glu,Tyr)4 as substrate assessed as inhibition of [33P]Phosphate incorporation into substrate after 80 min...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 25nMAssay Description:Inhibition of mouse recombinant CLK1 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 3(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant DYRK3 expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of mouse recombinant CLK1 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK4(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of mouse recombinant CLK4 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of human recombinant DYRK2 expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Inhibition of human recombinant DYRK1A expressed in Escherichia coli using RS peptide as substrateMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK4(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibition of mouse recombinant CLK4 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK4(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of mouse recombinant CLK4 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK1(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 53nMAssay Description:Inhibition of mouse recombinant CLK1 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:The compounds were determined using the Molecular Devices IMAP PDE Fluorescence Polarization assay using recombinant human PDE-10 enzyme expressed in...More data for this Ligand-Target Pair
TargetDual specificity protein kinase CLK2(Mus musculus)
Technische Universit£T Braunschweig
Curated by ChEMBL
Technische Universit£T Braunschweig
Curated by ChEMBL
Affinity DataIC50: 55nMAssay Description:Inhibition of mouse recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate after 30 mins by scintillation counting analysisMore data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Sunovion Pharamaceuticals
US Patent
Sunovion Pharamaceuticals
US Patent
Affinity DataIC50: 55nMAssay Description:In one embodiment, the compounds provided herein were assayed for their ability to inhibit human PDE-10A. In one embodiment, the activities of the co...More data for this Ligand-Target Pair